Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial

Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:43:59.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:46:00.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:03.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a simple header and Home link, replacing the prior study record details. This indicates access to the trial information is restricted and the details are not currently viewable.
    Difference
    18%
    Check dated 2026-09-23T00:44:56.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the page's revision history and the older v3.6.6 entry was removed, indicating a minor update to the page's revision tracking.
    Difference
    0.0%
    Check dated 2026-09-15T23:48:20.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This represents a small site revision label, likely reflecting an internal update without altering visible study information.
    Difference
    0.0%
    Check dated 2026-09-01T19:28:09.000Z thumbnail image

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.